Canland Health Corp. Applies for Temporary Exemption from Filing Its Quarterly Report for the Period Ended May 31, 2020 (Q1)

VANCOUVER, BC / ACCESSWIRE / August 4, 2020 / Canland Health Corp. (the “Company”), due to ongoing non-essential business shut down for COVID-19 measures taken by the Province of British Columbia, is relying on the exemption in BC Instrument 51-517 issued by the British Columbia Securities Commission and the reciprocating similar instrument issued by the Alberta Securities Commission allowing it to delay the filing of its interim financial statements, management discussion & analysis, and CEO & CFO certifications for the quarter ending May 31, 2020 (the “Filings”) as normally required under parts 4 and 5 of National Instrument 51-102 — Continuous Disclosure Obligations and Part 5 of National Instrument 52-109 – Certification of Disclosure in Issuers’ Annual and Interim Filings.

As required by BC Instrument 51-517, the Company provides the following updates and information for investors:

  • it is impractical, with the provincial shut down of non-essential business, to complete and file the quarterly financial statements as scheduled;

  • all Company executives and directors and insiders are subject to a trading black-out policy that reflects the principles in section 9 of National Policy 11-207

  • Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions until the quarterly financial statements are filed;

  • except as otherwise disclosed, no material business developments have occurred since filing of the Company’s interim financial statements for the period ended November 30, 2019;

  • management continues to seek viable business opportunities;

  • management estimates that it will be able to file the Filings by August 31, 2020; and

  • should material business developments occur, the Company will update shareholders accordingly.

About Canland Health Corp.

Canland Health Corp. is in the business of venture capital and investment in the Canadian healthcare sector.

For further information please contact:

Jacky Fu, CFO and director
E-mail: jfu@canlandhc.com

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company. Although the Company believes that the expectations and assumptions on which such forward-looking information is based on are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

SOURCE: Canland Health Corp.

View source version on accesswire.com:
https://www.accesswire.com/600264/Canland-Health-Corp-Applies-for-Temporary-Exemption-from-Filing-Its-Quarterly-Report-for-the-Period-Ended-May-31-2020-Q1

Staff

Recent Posts

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today…

39 minutes ago

Mexico’s EHR Revolution: Driving Digital Health Innovation and Market Growth, Insights From Black Book Research

Key Trends, Vendor Performance, and Opportunities Transforming Mexico's Healthcare IT Landscape MIAMI, FLORIDA / ACCESSWIRE…

39 minutes ago

Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees

Burlington, Ontario--(Newsfile Corp. - December 24, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or…

4 hours ago

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology…

4 hours ago

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out

PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused…

4 hours ago

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

7 hours ago